As I mentioned at the top, the stock is down 42% from its record high, which was set in 2021. It was unquestionably ...

One stock that fits this criteria is Philip Morris International ( PM -0.65%). This misunderstood nicotine giant is posting ...

In the wake of the U.S. presidential election, Tesla (NASDAQ: TSLA) stock surged to levels not seen in more than two years, ...

The U.S. is one of the world's wealthiest countries, but emerging markets could offer the best investment opportunities ...

Lender Upstart Holdings Inc. posted positive surprises across the board Thursday, and its stock soared about 20% higher in ...

The management aims for a positive growth trajectory in the par segment and expects strong growth to continue in the non-par ...

Gold Royalty Corp is a promising investment opportunity with exposure to high-quality gold royalties and potential for growth ...

The strength of the market response has arguably been at odds with what many economists consider the prospect of worse ...

Investors might be reluctant to buy Nu's stock after its 80% year-to-date rally, but I think it's still a terrific growth ...

TriplePoint Venture Growth reported Q3 earnings which showed some signs of improvement. Check out why I upgraded my rating on ...

Analyst Carter Gould of Barclays maintained a Buy rating on AbbVie (ABBV – Research Report), retaining the price target of $212.00.